These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7567696)

  • 1. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin.
    Huber PR; Mattarelli G; Strittmatter B; van Steenbrugge GJ; Schmid HP; Maurer A
    Prostate; 1995 Sep; 27(3):166-75. PubMed ID: 7567696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
    Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
    Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technicon Immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis.
    Zhou Z; Ng PC; Very DL; Allard WJ; Yeung KK
    J Clin Lab Anal; 1996; 10(3):155-9. PubMed ID: 8731504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disagreement between the Roche Cobas Core and Hybritech TANDEM-E PSA assays when measuring free, complexed and total serum prostate specific antigen.
    Tillyer CR; Konings M; Gobin PT; Iqbal J
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():501-5. PubMed ID: 7530440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease.
    España F; Martínez M; Sánchez-Cuenca J; Vera CD; Estellés A; Jiménez-Cruz JF
    Eur Urol; 1996; 30(4):512-8. PubMed ID: 8977078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate.
    Huber PR; Schmid HP; Mattarelli G; Strittmatter B; van Steenbrugge GJ; Maurer A
    Prostate; 1995 Oct; 27(4):212-9. PubMed ID: 7479388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors.
    Coker CB; Coptcoat MJ; Mulvin D; Cuomo A; Scott N; Sherwood R
    Br J Urol; 1998 Jan; 81(1):105-8. PubMed ID: 9467485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
    Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
    J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free/total prostate-specific antigen ratio--hope and controversies.
    Ravery V; Boccon-Gibod L
    Eur Urol; 1997; 31(4):385-8. PubMed ID: 9187894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
    Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
    J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum.
    Zhang WM; Finne P; Leinonen J; Vesalainen S; Nordling S; Stenman UH
    Clin Chem; 1999 Jun; 45(6 Pt 1):814-21. PubMed ID: 10351990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples.
    España F; Royo M; Martínez M; Enguídanos MJ; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF; Heeb MJ
    J Urol; 1998 Dec; 160(6 Pt 1):2081-8. PubMed ID: 9817329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME; Mazo EB; Chekhonin VP
    Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
    Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
    Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical finding of alpha-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer.
    Tanaka M; Suzuki Y; Takaoka K; Murakami S; Suzuki N; Shimazaki J
    Int J Urol; 1999 Dec; 6(12):600-6. PubMed ID: 10609542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
    Lilja H; Cockett AT; Abrahamsson PA
    Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostate specific antigen binding alpha 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones.
    Stamey TA; Chen Z; Prestigiacomo A
    J Urol; 1994 Nov; 152(5 Pt 1):1510-4. PubMed ID: 7523708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.
    Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA
    Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.